Skip to main content
C-RAD logo

C-RAD — Investor Relations & Filings

Ticker · CRAD ISIN · SE0002016352 LEI · 549300SPXLHF15W2CU25 ST Manufacturing
Open in API
Filings indexed 534 across all filing types
Latest filing 2016-11-21 Legal Proceedings Report
Country SE Sweden
Listing ST CRAD

About C-RAD

https://c-rad.com/

C-RAD is a medical technology company that develops and supplies solutions for advanced radiation therapy. The company's core offering is its Surface Guided Radiation Therapy (SGRT) technology, which provides high-precision patient positioning, real-time intra-fractional motion management, and respiratory gating. These systems are designed to increase treatment accuracy, enhance patient safety, and improve workflow efficiency in radiation oncology clinics. C-RAD's product portfolio also includes solutions for tumor localization and workflow automation, aiming to help clinicians deliver effective radiotherapy treatments, improve clinical outcomes, and enhance the quality of life for cancer patients.

Recent filings

Filing Released Lang Actions
Överklagande av dom avseende C-RAD’s patenträttigheter
Legal Proceedings Report Classification · 1% confidence The document is a press release dated November 21, 2016, detailing an update on a legal dispute concerning patent rights. Specifically, it mentions that the opposing party has appealed a previous court ruling regarding C-RAD's patent for 'Patient Monitoring Radiation Machines'. This content directly relates to significant lawsuits and regulatory/legal matters involving the company. According to the definitions, 'Legal Proceedings Report (LTR)' covers updates on significant lawsuits and regulatory actions. Although it is a press release, the core subject matter is the legal proceeding update, making LTR the most specific fit over the general 'RNS' fallback.
2016-11-21 Swedish
Kommuniké från extra bolagsstämma i C-RAD AB den 17 november 2016: bolagsstämman godkänner förslag om riktad emission
AGM Information Classification · 1% confidence The document is a press release dated November 17, 2016, titled 'Kommuniké från extra bolagsstämma' (Communication from the Extraordinary General Meeting) which explicitly states that the EGM approved a proposal for a directed share issue ('riktad emission'). This action directly relates to changes in the company's capital structure and fundraising activities. While it mentions the EGM, the core subject is the capital change (issuance of 600,000 B-shares for 6.5 Mkr). This fits best under 'Capital/Financing Update' (CAP) as it details the result of a financing activity approved by shareholders. It is not a general AGM presentation (AGM-R) or a declaration of general voting results (DVA), but a specific announcement about a capital change.
2016-11-17 Swedish
St. Vincent’s Private Hospital - den första C-RAD Catalyst™-kunden i Irland
Regulatory Filings Classification · 1% confidence The document is a press release dated 2016-11-16, written in Swedish, announcing a significant order (over 2.5 MSEK) from St. Vincent's Private Hospital in Ireland for C-RAD's Catalyst HD™ and Sentinel 4DCT™ systems. It details the product, delivery timeline, and includes quotes from management. The final paragraph explicitly states: "Denna information är sådan information som C-RAD AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning." (This information is such information that C-RAD AB (publ) is obliged to disclose under the EU Market Abuse Regulation.) This indicates a mandatory regulatory disclosure regarding a significant business event (a large order/sale). Since it is a press release announcing a business event rather than a formal financial report (10-K, IR, ER) or a specific insider/shareholder action (DIRS, MRQ, DIV), the most appropriate general category for a mandatory regulatory announcement that doesn't fit elsewhere is 'Regulatory Filings' (RNS). It is too detailed to be a simple Report Publication Announcement (RPA) which usually just points to another document.
2016-11-16 Swedish
St. Vincent’s Private Hospital first customer in Ireland for advanced C-RAD Catalyst™ system
Regulatory Filings Classification · 1% confidence The document is a press release dated 2016-11-16 announcing a specific business event: St. Vincent's Private Hospital becoming the first customer in Ireland for C-RAD's Catalyst™ system, detailing the order value and installation schedule. This is a general corporate announcement regarding a significant sale/contract, not a mandatory financial filing like a 10-K, IR, or ER. It does not fit the definitions for AGM-R, AR, MANG, CT, CAP, DVA, DLST, DIRS, SR, FS, CGR, IRAT, IP, LTR, TAR, MRQ, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. It is not a transcript (CT) or a detailed financial report (10-K, IR). Since it is a specific corporate announcement that doesn't fit the highly specific financial/regulatory categories, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory/corporate announcements not covered elsewhere, especially given the final sentence referencing EU Market Abuse Regulation obligations.
2016-11-16 English
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for an individual named Per Hamberg in C-Rad AB. It explicitly mentions 'Reason for major shareholding notification New share issue' and provides detailed tables showing the number of shares and voting rights before and after the transaction, including percentages. This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized as 'MRQ' (Major Shareholding Notification). The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2016-11-14 English
Earnings Release 2016
Earnings Release Classification · 1% confidence The document is titled "C‐RAD AB ‐ Delårsrapport januari ‐ september 2016" and contains detailed financial figures, key performance indicators (KPIs) like net sales, order intake, operating result, and earnings per share, covering the first nine months of 2016 (Q3 report). The structure, content (financial tables, management commentary on results), and reporting period (interim/quarterly) strongly indicate this is a comprehensive interim financial report, not just a brief announcement. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). The document length (46,033 chars) also suggests it is the full report, not a short announcement (RPA/RNS). 9M 2016
2016-11-14 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.